IDT Biologika GmbH, a global integrated contract manufacturer
of vaccines and biopharmaceuticals, today introduced plans to expand its viral
vaccine production capacity with the addition of a new high-speed filling line and
additional lyophilization capacity. The company also announced the addition of
80 employees to its workforce – an increase of approximately 11 % – to meet
growth in demand for its biologics production.
Dr. Ralf Pfirmann, CEO of IDT Biologika, said, “We are
proud to be one of the few industrial service manufacturers in the world with
the capacity and expertise to handle large-scale campaign manufacture of
various vaccines and biopharmaceuticals. In light of the resurgence of interest
by large pharma in developing new vaccines and the planned expansion of our
filling capacity, IDT remains well positioned to provide ongoing best-in-class service
to these innovative companies; from the bench through clinical development and
commercial production. In addition, as one of the premiere quality outsourcing
partners in Europe for global biotech
companies – particularly in the complex area of biologics – our recent
workforce expansion will accommodate increased demand in this area, and ensure
the highest levels of efficiency and quality for our customers.” IDT Biologika
expects to expand its extraordinarily flexible, multipurpose vaccine
manufacturing facilities via the completion of its new high-speed viral vaccine
line by mid-2013. This line will substantially expand fill-finish capacity and
well position the company for anticipated growth in demand for this service.
The company’s existing vaccine facility features two contained manufacturing
lines with segregated operations for preparation of cells, virus propagation
and virus purification. All IDT Biologika facilities have been inspected by
international regulatory agencies such as the European Medicines Agency (EMA)
and the U.S.
Food and Drug Administration (FDA).
“For the past two decades, we have and continue to
invest in state-of-the-art facilities, design and human expertise,” continued
Mr. Pfirmann. “In addition, beyond our equipment and technical know-how, we
believe in taking a collaborative wholeproject approach that allows us to
respond to customers’ needs in very short timeframes as opposed to working on a
turnkey basis. We look forward to seeing current partners and meeting potential
new customers at ICSE 2010.”
